Siemens Healthineers (FKA Varian Medical Systems, INC.)
Medical device manufacturer
Based in DC
🤖
AI Overview
With $1.9M in lobbying spend across 33 quarterly filings, Siemens Healthineers (FKA Varian Medical Systems, INC.) is a significant lobbying presence. They deploy 28 individual lobbyists Their lobbying covers 7 issue areas. Active from 2018 to 2025.
$1.9M
Total Spend
8
Years Active
1
Firms Hired
28
Lobbyists Deployed
7
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $140K |
| 2019 | $220K |
| 2020 | $300K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
Stephen KhoBrian PomperJustin MccarthyBrendan DunnFrancine FriedmanChristina HaleyChristopher TreanorCasey HigginsCaryn LesterVic FazioJulie NolanLauren O'brienGeoff VerhoffVirgil MillerHeide BajnrauhJose BorjonSam OlswangerLouis AgnelloSean FeelyGalen RoehlMichael BarnardAnna AbramFilemon VelaEd PaganoEric EttorreMia HeckJocelyn WilesKelly Ann Shaw
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade, Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent and 2 more
- •USTR 301 Action.
- •USTR 301 action
- •Issues relating to cancer radiotherapy treatment equipment.
Related Analysis
Related Investigations
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.